Seeking Clues to Ecolab (ECL) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Werte in diesem Artikel
Wall Street analysts forecast that Ecolab (ECL) will report quarterly earnings of $1.82 per share in its upcoming release, pointing to a year-over-year increase of 18.2%. It is anticipated that revenues will amount to $4.02 billion, exhibiting an increase of 1.7% compared to the year-ago quarter.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.That said, let's delve into the average estimates of some Ecolab metrics that Wall Street analysts commonly model and monitor.The combined assessment of analysts suggests that 'Sales- Global Healthcare and Life Sciences (Fixed currency)' will likely reach $330.73 million. The estimate suggests a change of -17.5% year over year.Analysts expect 'Sales- Global Industrial (Public Currency rates)' to come in at $2.00 billion. The estimate indicates a change of +8.5% from the prior-year quarter.Based on the collective assessment of analysts, 'Sales- Global Institutional & Specialty (Fixed currency)' should arrive at $1.40 billion. The estimate suggests a change of +6.9% year over year.It is projected by analysts that the 'Sales- Global Institutional & Specialty (Public Currency rates)' will reach $1.39 billion. The estimate indicates a change of +5.8% from the prior-year quarter.The consensus estimate for 'Sales- Global Industrial (Fixed currency)' stands at $2.00 billion. The estimate indicates a year-over-year change of +9.6%.The average prediction of analysts places 'Sales- Global Healthcare & Life Sciences (Public Currency rates)' at $363.51 million. The estimate indicates a year-over-year change of -10.5%.According to the collective judgment of analysts, 'Operating Income- Global Healthcare and Life Sciences (Fixed currency)' should come in at $27.11 million. Compared to the current estimate, the company reported $44 million in the same quarter of the previous year.Analysts predict that the 'Operating Income- Global Institutional & Specialty (Public Currency rates)' will reach $324.72 million. The estimate is in contrast to the year-ago figure of $250.80 million.Analysts forecast 'Operating Income- Global Industrial (Public Currency rates)' to reach $332.85 million. Compared to the current estimate, the company reported $289.80 million in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Operating Income- Global Industrial (Fixed currency)' of $331.73 million. The estimate compares to the year-ago value of $287.50 million.The consensus among analysts is that 'Operating Income- Global Institutional & Specialty (Fixed currency)' will reach $331.05 million. The estimate is in contrast to the year-ago figure of $249.90 million.Analysts' assessment points toward 'Operating Income- Global Healthcare & Life Sciences (Public Currency rates)' reaching $41.56 million. Compared to the present estimate, the company reported $45.20 million in the same quarter last year.View all Key Company Metrics for Ecolab here>>>Shares of Ecolab have demonstrated returns of +1.5% over the past month compared to the Zacks S&P 500 composite's +1.5% change. With a Zacks Rank #3 (Hold), ECL is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Ecolab
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ecolab
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ecolab Inc.
Analysen zu Ecolab Inc.
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ecolab Outperform | BMO Capital Markets | |
24.01.2018 | Ecolab Hold | Stifel, Nicolaus & Co., Inc. | |
07.11.2017 | Ecolab Outperform | RBC Capital Markets | |
12.09.2017 | Ecolab Outperform | RBC Capital Markets | |
02.08.2017 | Ecolab Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Ecolab Outperform | BMO Capital Markets | |
24.01.2018 | Ecolab Hold | Stifel, Nicolaus & Co., Inc. | |
07.11.2017 | Ecolab Outperform | RBC Capital Markets | |
12.09.2017 | Ecolab Outperform | RBC Capital Markets | |
02.08.2017 | Ecolab Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
03.04.2017 | Ecolab Neutral | Instinet | |
19.10.2015 | Ecolab Hold | Deutsche Bank AG | |
04.06.2015 | Ecolab Neutral | Global Hunter Securities | |
17.10.2011 | Ecolab neutral | Citigroup Corp. | |
29.07.2009 | Ecolab neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ecolab Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen